Clinical benefits of switching to insulin degludec irrespective of previous basal insulin therapy in people with Type 1 or Type 2 diabetes: evidence from a European, multicentre, retrospective, non‐interventional study (EU‐TREAT)

AIMS: To investigate whether the benefits of switching to insulin degludec observed in the European retrospective chart review study EU‐TREAT were dependent on the previous basal insulin used. METHODS: People with Type 1 or Type 2 diabetes were switched to insulin degludec from other basal insulins...

Descripción completa

Detalles Bibliográficos
Autores principales: Knudsen, S. T., Lapolla, A., Schultes, B., Tentolouris, N., Catarig, A.‐M., Wolden, M. L., Siegmund, T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6618263/
https://www.ncbi.nlm.nih.gov/pubmed/31001865
http://dx.doi.org/10.1111/dme.13976

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6618263/
https://www.ncbi.nlm.nih.gov/pubmed/31001865
http://dx.doi.org/10.1111/dme.13976

Ejemplares similares